ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $62,000 | -67.2% | 19,186 | -71.2% | 0.00% | -60.0% |
| Q1 2017 | $189,000 | +81.7% | 66,717 | +48.8% | 0.01% | +66.7% |
| Q4 2016 | $104,000 | +57.6% | 44,836 | +13.6% | 0.00% | +50.0% |
| Q3 2016 | $66,000 | +6.5% | 39,453 | -23.1% | 0.00% | +100.0% |
| Q4 2015 | $62,000 | +138.5% | 51,333 | +237.4% | 0.00% | – |
| Q3 2015 | $26,000 | -27.8% | 15,216 | -12.1% | 0.00% | -100.0% |
| Q2 2015 | $36,000 | -52.0% | 17,312 | -37.8% | 0.00% | -50.0% |
| Q1 2015 | $75,000 | +70.5% | 27,814 | +62.4% | 0.00% | +100.0% |
| Q4 2014 | $44,000 | -75.7% | 17,126 | -82.6% | 0.00% | -66.7% |
| Q3 2014 | $181,000 | +2.3% | 98,634 | +94.4% | 0.00% | +50.0% |
| Q1 2014 | $177,000 | +149.3% | 50,728 | +220.6% | 0.00% | +100.0% |
| Q4 2013 | $71,000 | -76.5% | 15,824 | -78.7% | 0.00% | -75.0% |
| Q3 2013 | $302,000 | – | 74,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |